Transmission dynamics reveal the impracticality of COVID-19 herd immunity strategies
暂无分享,去创建一个
[1] Christl A. Donnelly,et al. The impact of COVID-19 and strategies for mitigation and suppression in low- and middle-income countries , 2020, Science.
[2] Heba Habib. Has Sweden’s controversial covid-19 strategy been successful? , 2020, BMJ.
[3] A. Flahault,et al. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study , 2020, The Lancet.
[4] N. G. Davies,et al. Effects of non-pharmaceutical interventions on COVID-19 cases, deaths, and demand for hospital services in the UK: a modelling study , 2020, The Lancet Public Health.
[5] K. Abbasi,et al. The UK’s public health response to covid-19 , 2020, BMJ.
[6] P. Horby,et al. Features of 16,749 hospitalised UK patients with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol , 2020, medRxiv.
[7] W. Wei,et al. Presymptomatic Transmission of SARS-CoV-2 — Singapore, January 23–March 16, 2020 , 2020, MMWR. Morbidity and mortality weekly report.
[8] Chonggang Xu,et al. High Contagiousness and Rapid Spread of Severe Acute Respiratory Syndrome Coronavirus 2 , 2020, Emerging infectious diseases.
[9] A. Vespignani,et al. Evolving epidemiology and transmission dynamics of coronavirus disease 2019 outside Hubei province, China: a descriptive and modelling study , 2020, The Lancet Infectious Diseases.
[10] M. Mello,et al. Thinking Globally, Acting Locally - The U.S. Response to Covid-19. , 2020, The New England journal of medicine.
[11] P. Vollmar,et al. Virological assessment of hospitalized patients with COVID-2019 , 2020, Nature.
[12] C. Whittaker,et al. Estimates of the severity of coronavirus disease 2019: a model-based analysis , 2020, The Lancet Infectious Diseases.
[13] Carl A. B. Pearson,et al. The effect of control strategies to reduce social mixing on outcomes of the COVID-19 epidemic in Wuhan, China: a modelling study , 2020, The Lancet Public Health.
[14] David J. Hunter. Covid-19 and the Stiff Upper Lip - The Pandemic Response in the United Kingdom. , 2020, The New England journal of medicine.
[15] C. Whittaker,et al. Report 9: Impact of non-pharmaceutical interventions (NPIs) to reduce COVID19 mortality and healthcare demand , 2020 .
[16] Peng Wu,et al. Detection of Covid-19 in Children in Early January 2020 in Wuhan, China , 2020, The New England journal of medicine.
[17] Hannah R. Meredith,et al. The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application , 2020, Annals of Internal Medicine.
[18] Yonatan H. Grad,et al. Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period , 2020, Science.
[19] Yongsheng Wu,et al. Epidemiology and Transmission of COVID-19 in Shenzhen China: Analysis of 391 cases and 1,286 of their close contacts , 2020, medRxiv.
[20] T. Hollingsworth,et al. How will country-based mitigation measures influence the course of the COVID-19 epidemic? , 2020, The Lancet.
[21] R. Horton. Offline: COVID-19—a reckoning , 2020, The Lancet.
[22] A. Schuchat,et al. COVID-19: towards controlling of a pandemic , 2020, The Lancet.
[23] K. Yuen,et al. Clinical Characteristics of Coronavirus Disease 2019 in China , 2020, The New England journal of medicine.
[24] E. Dong,et al. An interactive web-based dashboard to track COVID-19 in real time , 2020, The Lancet Infectious Diseases.
[25] Min Kang,et al. SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients , 2020, The New England journal of medicine.
[26] Jing Zhao,et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia , 2020, The New England journal of medicine.
[27] N. Linton,et al. Incubation Period and Other Epidemiological Characteristics of 2019 Novel Coronavirus Infections with Right Truncation: A Statistical Analysis of Publicly Available Case Data , 2020, medRxiv.
[28] Y. Hu,et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China , 2020, The Lancet.
[29] G. Gao,et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019 , 2020, The New England journal of medicine.
[30] A. Handel,et al. Heterogeneity and longevity of antibody memory to viruses and vaccines , 2018, PLoS biology.
[31] A. King,et al. The impact of past vaccination coverage and immunity on pertussis resurgence , 2018, Science Translational Medicine.
[32] Pejman Rohani,et al. Combating pertussis resurgence: One booster vaccination schedule does not fit all , 2015, Proceedings of the National Academy of Sciences.
[33] Jérôme Hugues,et al. Model‐Based Analysis , 2013 .
[34] T. Déirdre Hollingsworth,et al. Mitigation Strategies for Pandemic Influenza A: Balancing Conflicting Policy Objectives , 2011, PLoS Comput. Biol..
[35] R. Mikolajczyk,et al. Social Contacts and Mixing Patterns Relevant to the Spread of Infectious Diseases , 2008, PLoS medicine.
[36] M. Keeling,et al. Modeling Infectious Diseases in Humans and Animals , 2007 .
[37] Pejman Rohani,et al. Appropriate Models for the Management of Infectious Diseases , 2005, PLoS medicine.
[38] J. Watmough,et al. Reproduction numbers and sub-threshold endemic equilibria for compartmental models of disease transmission. , 2002, Mathematical biosciences.
[39] A L Lloyd,et al. Realistic distributions of infectious periods in epidemic models: changing patterns of persistence and dynamics. , 2001, Theoretical population biology.
[40] S. Leeder,et al. A population based study , 1993, The Medical journal of Australia.
[41] R. May,et al. Infectious Diseases of Humans: Dynamics and Control , 1991, Annals of Internal Medicine.